Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Bruce Japsen
·
2026-06-09
·
via Forbes - Healthcare
Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wego…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。